8B58 image
Deposition Date 2022-09-22
Release Date 2023-02-01
Last Version Date 2023-02-22
Entry Detail
PDB ID:
8B58
Keywords:
Title:
Crystal Structure of Cyclophilin TgCyp23 from Toxoplasma gondii in complex with Cyclosporin A
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.10 Å
R-Value Free:
0.15
R-Value Work:
0.13
R-Value Observed:
0.13
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peptidyl-prolyl cis-trans isomerase
Chain IDs:A, B
Chain Length:211
Number of Molecules:2
Biological Source:Toxoplasma gondii
Polymer Type:polypeptide(L)
Molecule:Cyclosporin A
Chain IDs:C, D
Chain Length:11
Number of Molecules:2
Biological Source:synthetic construct
Peptide-like Molecules
PRD_000142
Primary Citation
Structural Basis for Cyclosporin Isoform-Specific Inhibition of Cyclophilins from Toxoplasma gondii .
Acs Infect Dis. 9 365 377 (2023)
PMID: 36653744 DOI: 10.1021/acsinfecdis.2c00566

Abstact

Cyclosporin (CsA) has antiparasite activity against the human pathogen Toxoplasma gondii. A possible mechanism of action involves CsA binding to T. gondii cyclophilins, although much remains to be understood. Herein, we characterize the functional and structural properties of a conserved (TgCyp23) and a more divergent (TgCyp18.4) cyclophilin isoform from T. gondii. While TgCyp23 is a highly active cis-trans-prolyl isomerase (PPIase) and binds CsA with nanomolar affinity, TgCyp18.4 shows low PPIase activity and is significantly less sensitive to CsA inhibition. The crystal structure of the TgCyp23:CsA complex was solved at the atomic resolution showing the molecular details of CsA recognition by the protein. Computational and structural studies revealed relevant differences at the CsA-binding site between TgCyp18.4 and TgCyp23, suggesting that the two cyclophilins might have distinct functions in the parasite. These studies highlight the extensive diversification of TgCyps and pave the way for antiparasite interventions based on selective targeting of cyclophilins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures